Radiopharm Theranostics (ASX:RAD) Construction In Progress: A$0.00 Mil (As of Jun. 2025)


What is Radiopharm Theranostics Construction In Progress?

Radiopharm Theranostics ASX:RAD Construction In Progress is A$0.00 Mil as of Jun. 2025. The stock has 5 warning signs investors should review.

Radiopharm Theranostics Construction In Progress Historical Data

* Premium members only.

The historical data trend for Radiopharm Theranostics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Radiopharm Theranostics Construction In Progress Chart

Radiopharm Theranostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Construction In Progress
0.00 0.00 0.00 0.00

Radiopharm Theranostics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Construction In Progress Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Radiopharm Theranostics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of A$0.00 Mil mean?
Radiopharm Theranostics (ASX:RAD) has a Construction In Progress of A$0.00 Mil as of Jun. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Radiopharm Theranostics and its competitors.
Is Radiopharm Theranostics' Construction In Progress too high?
Radiopharm Theranostics' current Construction In Progress is A$0.00 Mil.
How does Radiopharm Theranostics' Construction In Progress compare to VRTX and REGN?
Radiopharm Theranostics' Construction In Progress of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Radiopharm Theranostics and its competitors. Radiopharm Theranostics's current Construction In Progress is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Radiopharm Theranostics stock overvalued right now?
Radiopharm Theranostics (ASX:RAD) has a current Construction In Progress of A$0.00 Mil. The current Construction In Progress is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Radiopharm Theranostics (ASX:RAD), the current Construction In Progress is A$0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Radiopharm Theranostics Business Description

Other Exchanges RADX:USA
Address 62 Lygon Street, Suite 1, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.